(2017) Applying Bioinformatic Tools for Modeling and Modifying Type II E. coli l-Asparginase to Present a Better Therapeutic Agent/Drug for Acute Lymphoblastic Leukemia. Iranian Journal of Cancer Prevention. p. 10. ISSN 2008-2398